Cat. No. 2548
Chemical Name: 4,4',4'',4'''-[Carbonylbis[imino-5,1,3-be
Biological ActivityHigh affinity P2X3 receptor antagonist (Ki values are 36, 82 and 4144 nM for P2X3, P2X1 and P2X2 recombinant receptors respectively). Shows no activity at P2Y1, P2Y2 and P2Y11 receptors (IC50 > 10 μM). Potently inhibits α,β-meATP-evoked desensitizing currents in rat DRG neurons (IC50 = 527 nM). Shows antitumor activity against several tumor types.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Hausmann et al (2006) The suramin analog 4,4',4'',4'''-(Carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups. Mol.Pharmacol. 69 2058. PMID: 16551782.
Kassack et al (2004) Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist. Eur.J.Med.Chem. 39 345. PMID: 15072843.
Dhar et al (2000) Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients. Eur.J.Cancer 36 803. PMID: 10762755.
If you know of a relevant reference for NF 110 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses NF 110 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: NF 110, supplier, Potent, P2X3, antagonists, Receptors, Purinergic, purinoceptors, NF110, Tocris Bioscience, Purinergic (P2X) Receptor Antagonist products
Find multiple products by catalog number
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.